PE Tech Report


Like this article?

Sign up to our free newsletter

Kurma Partners targets EUR250m for first growth opportunities fund

Kurma Partners has held the first closing of its Growth Opportunities fund at EUR160 million.

Meeting the demand of the growing maturity of the European biotech and healthtech ecosystem, this new fund, which is targeting EUR250 million, aims to accelerate the growth of the best European companies in the healthcare sector. 

Kurma Partners has received the support of the European Investment Fund (EIF), Bpifrance, the Belgian Growth Fund managed by PMV and BNP Paribas Fortis Private Equity, SFPI, BNP Paribas Fortis and Groupe Pasteur Mutualité. Eurazeo, which recently increased its stake in Kurma Partners, is also an anchor investor in this fund.

The fund has been granted with the Tibi label making it eligible for the EUR6 billion mobilised by French institutional investors to accelerate the growth of innovative companies and turn them into national leaders with global ambitions.

Like this article? Sign up to our free newsletter